Casdin Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,360,129
| Closed | -$10.7M | – | 39 |
|
|
2024
Q1 | $10.7M | Hold |
2,360,129
| – | – | 0.79% | 24 |
|
|
2023
Q4 | $13.5M | Hold |
2,360,129
| – | – | 1.32% | 18 |
|
|
2023
Q3 | $10.9M | Sell |
2,360,129
-159,871
| -6% | -$735K | 1.2% | 21 |
|
|
2023
Q2 | $16.3M | Hold |
2,520,000
| – | – | 1.42% | 23 |
|
|
2023
Q1 | $19M | Buy |
2,520,000
+250,000
| +11% | +$1.89M | 1.57% | 18 |
|
|
2022
Q4 | $23M | Buy |
2,270,000
+620,000
| +38% | +$6.28M | 1.78% | 15 |
|
|
2022
Q3 | $16.3M | Buy |
1,650,000
+900,000
| +120% | +$8.9M | 1.07% | 20 |
|
|
2022
Q2 | $7.99M | Buy |
+750,000
| New | +$7.99M | 0.68% | 26 |
|
|
2021
Q1 | – | Sell |
-200,000
| Closed | -$8.05M | – | 49 |
|
|
2020
Q4 | $8.05M | Buy |
+200,000
| New | +$8.05M | 0.24% | 44 |
|